• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Recalcitrant Tinea Corporis as the Presenting Manifestation of Patch-Stage Mycosis Fungoides
Recalcitrant Tinea Corporis as the Presenting Manifestation of Patch-Stage Mycosis Fungoides

... increased to 200 mg twice daily. Six months later, the skin disease was in remission (Figure 5), and the patient discontinued all therapy. She has not had a recurrence of tinea corporis, onychomycosis, or cutaneous T-cell lymphoma for more than 5 years. ...
Graft-versus-host Disease* Causes GVHD may occur after a bone
Graft-versus-host Disease* Causes GVHD may occur after a bone

... Several lab and imaging tests can be done to diagnose and monitor problems caused by GVHD. A biopsy of the skin, mucus membranes in the mouth, or other parts of the body may help confirm the diagnosis. ...
Symptomatic Treatment of Multiple Sclerosis - MS-ID
Symptomatic Treatment of Multiple Sclerosis - MS-ID

... Specific treatments Physiotherapy Physiotherapy is generally accepted as a basic treatment option for spasticity even if controlled studies have only rarely been performed in patients with MS or other central nervous system disorders including stroke or spinal cord injury. To our knowledge, only one ...
Rituximab: An Autoimmune Disease Therapy
Rituximab: An Autoimmune Disease Therapy

... (polymyositis) or the skin, joints, esophagus or lungs (dermatomyositis) accompanied by weakness in the affected areas. As with pemphigus, standard treatments include corticosteroids or immunosuppressant drugs with IVIG use in patients unresponsive to these therapies. In one study of 13 patients wit ...
Bulletin 55 Amorolfine 5% nail lacquer
Bulletin 55 Amorolfine 5% nail lacquer

... for fingernail infection and 70–80% for toenail infection can be expected. The most common adverse effects12 (mild and transient) associated with terbinafine are nausea, mild abdominal pain, diarrhoea, and dyspepsia. These normally resolve on stopping treatment. Hepatotoxicity may occur in people wi ...
Functional outcome of myositis patients
Functional outcome of myositis patients

... however, that the use of very high starting doses (i.e. 1 - 2 mg prednisolone/kg/ day) (1-3) has never been validated. Two retrospective studies have suggested that PM-DM patients given a high dose GC regimen experienced a better biochemical and clinical outcome than patients given lower doses (4, 5 ...
Adverse Events in Phototherapy - Yorkshire Phototherapy Network
Adverse Events in Phototherapy - Yorkshire Phototherapy Network

... • Phototherapy involves exposure of the skin to ultraviolet light with or without the use of a phototoxic drug • Ultraviolet light is known to cause DNA damage and predispose to skin cancer • Phototherapy also has a number of other potential side-effects that need to be considered before starting t ...
PERIPHERAL NERVE INJURIES IN THE ATHLETE
PERIPHERAL NERVE INJURIES IN THE ATHLETE

... c. What’s the threshold for oral steroids & how often can they be repeated? ...
PAEDIATRIC GASTRO-OESOPHAGEAL REFLUX DISEASE (GERD
PAEDIATRIC GASTRO-OESOPHAGEAL REFLUX DISEASE (GERD

... The incidence of GER–related recurrent aspiration in normal infants and children is unknown, but appears to be rare. Some patient populations are prone to aspiration. The presence of neuromuscular disease or a history of laryngeal or oesophageal anatomic abnormalities increases the risk of aspiratio ...
Developing Leadership Skills for Clinical Practice Through
Developing Leadership Skills for Clinical Practice Through

... Board certifications “The specialist certification program was established to provide formal recognition for physical therapists with advanced clinical knowledge, experience, and skills in a special area of practice and to assist consumers and the health care community in identifying these physical ...
Zapping Varicose Veins - STA HealthCare Communications
Zapping Varicose Veins - STA HealthCare Communications

... pregnancy, complex genetic predisposition, female gender (it is two to three times more common in women) and occupation (prolonged standing or sitting).3 A leg ulcer can develop three to seven years later in 5% to 7% of patients with deep venous thrombosis (DVT).4 Studies show that patients with chr ...
Facial Fillers, Botulinum Toxin, and Facial Rejuvenation
Facial Fillers, Botulinum Toxin, and Facial Rejuvenation

... to replace a physician’s own judgment or give specific advice for case management. Including all indications, contraindications, side effects, and alternative agents for each drug or treatment is beyond the scope of this material. All information and recommendations should be verified, prior to use, ...
Hyponatraemia in Primary Care
Hyponatraemia in Primary Care

... Who can be managed in primary care •Mild hyponatraemia (Na 125-133mmol/L) and asymptomatic patients can be managed in primary care. •All patients with new onset hyponatraemia should have a repeat Na checked after 1 week to exclude a rapidly decreasing level. ...
Fasting and Medicines in Ramadhan
Fasting and Medicines in Ramadhan

... There are three stages to the fast during Ramadhan. Firstly there is the pre-dawn breakfast, which should consist of a meal and water. The fasting period runs from dawn to sunset. At sunset the fast is broken with a small snack and dinner is eaten in the evening. There is no need for excess. All pat ...
Treatment-related symptom management in patients with
Treatment-related symptom management in patients with

... Lenalidomide is approved in combination with dexamethasone for treating patients with MM who have received ≥1 prior therapy, and is often used in frontline/ induction therapy for both ASCT-eligible and -ineligible patients and in maintenance or salvage therapy regimens [12, 36]. Lenalidomide appears ...
Product Information - Therapeutic Goods Administration
Product Information - Therapeutic Goods Administration

... cells. PlGF binds only to VEGFR-1, which is also present on the surface of leukocytes. Excessive activation of these receptors by VEGF-A can result in pathological neovascularisation and excessive vascular permeability. PlGF can synergise with VEGFA in these processes, and is also known to promote l ...
Clinical Pharmacy in Immunoallergology.Medical diseases
Clinical Pharmacy in Immunoallergology.Medical diseases

... back of the throat, combined with increased sensitivity, can also lead to throat irritation and redness. AR usually also causes redness, itching, and watery eyes. Fatigue and headache are also common. ...
Parameter on Chronic Periodontitis With Slight to Moderate Loss of
Parameter on Chronic Periodontitis With Slight to Moderate Loss of

... Chronic periodontitis is defined as inflammation of the gingiva extending into the adjacent attachment apparatus. The disease is characterized by loss of clinical attachment due to destruction of the periodontal ligament and loss of the adjacent supporting bone. Clinical Features Although chronic pe ...
Respiratory Bronchiolitis-Associated Interstitial Lung Disease
Respiratory Bronchiolitis-Associated Interstitial Lung Disease

... had evidence on lung biopsy results of proliferative vasculopathy involving muscular arteries and veins. Patients should be monitored closely (approximately every 3 months) following diagnosis in order to identify patients with these risk factors, for whom a trial of corticosteroids and/or early con ...
02 December 2014
02 December 2014

... selexipag, a first orally-available, selective IP prostacyclin receptor agonist for patients suffering from pulmonary arterial hypertension (PAH). This compound was originally discovered and synthesized by Nippon Shinyaku. Actelion is responsible for global development and commercialization of selex ...
Hepatitis C - National Health Care for the Homeless Council
Hepatitis C - National Health Care for the Homeless Council

... enormous obstacles to specialty and other health care clinics, including language barriers and a lack of insurance, transportation, and housing. Health care professionals trained in the monitoring and treatment of HCV should ideally be available at health care for the homeless clinics. While the man ...
Clinical Trials in Glaucoma
Clinical Trials in Glaucoma

... - How often NTG is progressive? - Whether reducing IOP by 30% from baseline (w either meds or surgery) preserve visual function - How frequently treatment is protective against further damage  2 treatment groups - Treatment or No treatment  202 patients randomized into study  Only one eye enrolle ...
Inflammatory Bowel Disease 2016 What`s In The Pipeline?
Inflammatory Bowel Disease 2016 What`s In The Pipeline?

... • Level of target may be influenced by comorbidities and drugrelated risks • Desired target should be maintained indefinitely • Use both symptoms and objective measures of inflammation (endoscopic or radiologic) to guide treatment decisions • Assess mucosal healing every 6 months till target is achi ...
Vasculitis and Bullous Pemphigoid
Vasculitis and Bullous Pemphigoid

... vascular walls), then there will be pathologic support for the diagnosis.1 Although the final test results will take anywhere from a few days to many weeks, it is a crucial part of the puzzle. It is important because vasculitis is a clinicopathologic process characterized by inflammation and necrosi ...
What`s new! - Lyme Disease Association of Southeastern
What`s new! - Lyme Disease Association of Southeastern

... – Rapid relapse of symptoms if treatment ended too soon or if treatment not optimal BABESIA– Abrupt onset of initial illness, obvious sweats especially at night, cycles every few days – Fatigue, global headaches, air hunger, cough, hypercoaguable (responds to Heparin) – Very severe Lyme symptoms and ...
< 1 ... 264 265 266 267 268 269 270 271 272 ... 462 >

Management of multiple sclerosis



Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report